Brent Saunders, JD

Chairman of the Board of Directors

Brent Saunders has over 25 years of experience in leadership roles at several prominent global pharmaceutical and healthcare companies. He currently serves as CEO and Chairman of Bausch + Lomb (NYSE:BLCO). He previously served as CEO of the company from March 2010 until August 2013, until its acquisition by Valeant (NYSE:BHC). Previously, he served as CEO, President and Chairman of Vesper Healthcare. Before this, he served as Chairman, President and Chief Executive Officer of Allergan until its acquisition by AbbVie in May 2020. Prior to this, Brent served as Chief Executive Officer of Forest Laboratories Inc., a role he held until the company’s merger with Actavis in 2014. Following the merger with Actavis, Brent was named Chief Executive Officer of the combined business and in 2015, he led Actavis’ acquisition by Allergan. Mr. Saunders holds a B.A. degree from the University of Pittsburgh, a J.D. degree from the Temple University School of Law, and an MBA from the Temple University School of Business.